+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896509
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Computational Biology Market grew from USD 6.25 billion in 2023 to USD 7.42 billion in 2024. It is expected to continue growing at a CAGR of 18.91%, reaching USD 21.01 billion by 2030.

It encompasses the development and application of theoretical methods and data-analytical, computational simulation techniques, and mathematical modeling to the study of biological, behavioral, and social systems. The primary aim of this technology is to generate insights into the principles and dynamics of biological systems, as well as to predict their behaviors and interactions. Computational biology is closely related to the field of bioinformatics but tends to focus more on the development of theoretical approaches and computational models. The computational biology market is driven by the increasing need for drug discovery and personalized medicine, advancements in the field of bioinformatics, and the rise in the volume of complex biological data. Government and private funding for research and development in genomics and proteomics also support the market expansion. Despite growth prospects, the need for specialized computational infrastructure, high costs associated with computational tools, and a shortage of skilled professionals to analyze biological data hinder the scope of computational biology. Moreover, concerns regarding data security and privacy and the complexity of regulatory compliances for healthcare-related data create hurdles in market proliferation. However, an integration of artificial intelligence and machine learning algorithms is further presenting lucrative opportunities for market growth by enhancing predictive modeling and data analysis capabilities. Moreover, the rising focus on biomarker discovery and its role in precision medicine opens up new opportunities for the market's expansion.

Regional Insights

The computational biology market in the Americas, particularly in North America, is exhibiting robust growth. The presence of established pharmaceutical companies, sophisticated healthcare infrastructure, and rigorous research and development activities are propelling the region's market expansion. Large-scale investments in genomics and proteomics are further spurring demand for computational biology solutions. The United States remains at the forefront, backed by supportive government policies, substantial academic-industry collaborations, and an increase in bioinformatics-related courses that supply skilled professionals to the field. The EMEA region has been experiencing a significant surge in the computational biology market owing to increased funding by private and public entities, particularly in Europe. Efficient regulatory frameworks for drug development and a tradition of excellence in scientific research are driving the market's progress in this region. Germany, the UK, and France are major contributors with their strong focus on biotechnology and computational sciences. The Middle East is steadily catching up, largely due to strategic government investments in the biotech sector, while Africa is in the early stages of development. Asia-Pacific is emerging as a dynamic growth hub for the computational biology market. Rapid economic development, increasing healthcare expenditure, and a burgeoning biotechnology industry characterize the market landscape. Countries in the region are providing lucrative opportunities for market players owing to governmental backing, a focus on education and research in the life sciences, and a rising emphasis on personalized medicine. Cross-border collaborations and the inflow of foreign investments are further defining this market, positioning APAC as a competitive and high-potential region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Computational Biology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising Need for Personalized Medicine
  • Growing Bioinformatics Research and Increasing Number of Clinical Studies
  • Adoption of Computational Biology in Oncology Therapeutics

Market Restraints

  • Dearth of Skilled Professionals to Operate Computational Tools

Market Opportunities

  • Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
  • Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology

Market Challenges

  • Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards

Market Segmentation Analysis

  • Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
  • Application: Significant applications of computational biology to streamline the drug development pipeline
  • End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Computational Biology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Computational Biology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences

Genome Canada announced its collaboration with the Canadian Institutes of Health Research (CIHR), specifically with the Institutes of Aging, Cancer Research, Genetics, Infection and Immunity, and Musculoskeletal Health and Arthritis, in launching the 2024/25 Health Research Training Platform (HRTP). This initiative, bolstered by partnerships with the Centre for Research on Pandemic Preparedness and Health Emergencies and Mitacs, aims to nurture a diverse group of trainees and early career researchers through interdisciplinary training platforms. With a commitment of USD 6,050,000 for the bioinformatics, computational biology, and health data sciences pool, these funds are dedicated to offering substantial support to a single project that demonstrates potential for profound impact.

Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners

Pluto announced a significant milestone with the completion of a USD 3.7 million seed financing round, led by Silverton Partners, aimed at propelling the evolution of biological data assessment and multiplying the pace of discoveries within the life sciences domain globally. Boasting an intuitive web-based interface, Pluto's computational biology platform is at the forefront of enhancing researcher capability in the analysis, visualization, and interpretation of complex biological information.

Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

Accenture PLC has strategically enhanced its technological footprint through an investment in Ocean Genomics via Accenture Ventures' Project Spotlight. Ocean Genomics specializes in computational platforms powered by artificial intelligence, revolutionizing the biopharmaceutical sector's approach to diagnostics and drug development. Their innovative solutions delve into the intricate world of mRNA, enabling the prediction of individual responses to medical treatments with greater accuracy.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Computational Biology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd., Dassault Systèmes SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, Genedata AG, Illumina, Inc., Insilico Medicine, Instem Group, Nimbus Discovery Llc, Ocean Genomics, PerkinElmer, Inc., Pluto Bioinformatics, ProFound Therapeutics, QIAGEN N.V., Rosa & Co. Llc, Schrodinger, Inc., Simulation Plus Inc., SOPHiA GENETICS, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi NextCODE.

Market Segmentation & Coverage

This research report categorizes the Computational Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services

  • Contract
  • In-house

Application

  • Cellular Biological Simulation
  • Clinical Trials
  • Drug Discovery & Disease Modelling
  • Human Body Simulation Software
  • Preclinical Drug Development

End-Use

  • Academics
  • Commercial

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Need for Personalized Medicine
5.1.1.2. Growing Bioinformatics Research and Increasing Number of Clinical Studies
5.1.1.3. Adoption of Computational Biology in Oncology Therapeutics
5.1.2. Restraints
5.1.2.1. Dearth of Skilled Professionals to Operate Computational Tools
5.1.3. Opportunities
5.1.3.1. Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
5.1.3.2. Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
5.1.4. Challenges
5.1.4.1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards
5.2. Market Segmentation Analysis
5.2.1. Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
5.2.2. Application: Significant applications of computational biology to streamline the drug development pipeline
5.2.3. End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Computational Biology Market, by Services
6.1. Introduction
6.2. Contract
6.3. In-house
7. Computational Biology Market, by Application
7.1. Introduction
7.2. Cellular Biological Simulation
7.3. Clinical Trials
7.4. Drug Discovery & Disease Modelling
7.5. Human Body Simulation Software
7.6. Preclinical Drug Development
8. Computational Biology Market, by End-Use
8.1. Introduction
8.2. Academics
8.3. Commercial
9. Americas Computational Biology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Computational Biology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Computational Biology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences
12.3.2. Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners
12.3.3. Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. COMPUTATIONAL BIOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COMPUTATIONAL BIOLOGY MARKET DYNAMICS
FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 52. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 53. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 58. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 59. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 86. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 87. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 92. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 93. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 104. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 105. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 108. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 140. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 141. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 160. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 161. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 164. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 165. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 166. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 167. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 172. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 173. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 178. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 179. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 184. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 185. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 188. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 196. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 197. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 213. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 214. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 215. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 220. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 221. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 226. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 227. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 250. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 251. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 268. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 269. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 285. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Agilent Technologies, Inc.
  • BGI Group
  • Biomax Informatics AG
  • Chemical Computing Group Inc.
  • Compugen Ltd.
  • Dassault Systèmes SE
  • DNAnexus, Inc.
  • DNASTAR, Inc.
  • Eurofins Scientific SE
  • Genedata AG
  • Illumina, Inc.
  • Insilico Medicine
  • Instem Group
  • Nimbus Discovery Llc
  • Ocean Genomics
  • PerkinElmer, Inc.
  • Pluto Bioinformatics
  • ProFound Therapeutics
  • QIAGEN N.V.
  • Rosa & Co. Llc
  • Schrodinger, Inc.
  • Simulation Plus Inc.
  • SOPHiA GENETICS
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • WuXi NextCODE

Methodology

Loading
LOADING...

Table Information